Physician profile
John C Carter
NPI 1659660801
$13,913.04
in general payments reported to CMS, 2019-2025
8 companies · $9,537 in 2025
The $9,537 reported for 2025 was more than what 92% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $126 · 2020: $657 · 2022: $165 · 2023: $3,037 · 2024: $392 · 2025: $9,537.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,487 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,000 · Food and Beverage: $1,651 · Travel and Lodging: $701 · Education: $127.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,486.67 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,000.00 |
| Food and Beverage | $1,650.96 |
| Travel and Lodging | $700.93 |
| Education | $126.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fisher & Paykel Healthcare INC | $5,100.00 | 2023-2025 | Fisher & Paykel Healthcare |
| Avadel Cns Pharmaceuticals, LLC | $4,891.35 | 2024-2025 | Lumryz |
| Inspire Medical Systems, INC. | $2,327.83 | 2019-2025 | Inspire |
| Zoll Medical Corporation | $610.00 | 2023 | |
| Vertex Pharmaceuticals Incorporated | $516.67 | 2025 | |
| Harmony Biosciences LLC | $380.50 | 2020-2025 | Wakix |
| Jazz Pharmaceuticals INC. | $70.00 | 2022 | |
| Axsome Therapeutics, INC. | $16.69 | 2023 | Sunosi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Carter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.